Should I Buy ASST? ASST 2026 Analysis

Should You Buy Strive Inc (ASST) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

0.790

1 Day change

-1.87%

52 Week Range

13.420

Analysis Updated At

2026/01/28

ASST is not a good buy right now for a Beginner long-term investor with $50k–$100k who is impatient about waiting for better entries. The stock is in a clear downtrend (bearish moving averages and weakening momentum), recent pattern-based odds lean negative over the next week, and the company is actively raising significant preferred capital ($150M planned) which is an overhang. Despite very bullish options positioning and one supportive analyst initiation, the current setup favors staying on the sidelines rather than buying now.

Technical Analysis

Trend/momentum is bearish. Moving averages are stacked negatively (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend. MACD histogram is negative (-0.0105) and expanding lower, suggesting downside momentum is strengthening rather than stabilizing. RSI(6)=35.5 is near the low end of neutral and close to oversold, but it is not showing a confirmed reversal signal. Price context: pre-market ~0.8346, which is below the pivot (0.945), implying the stock is trading in a weaker zone. Near-term support is S1=0.788 (then S2=0.691); resistance levels are R1=1.101 and R2=1.198. The pattern-based projection provided also leans bearish: ~70% chance of -5.86% over the next week and -2.61% over the next month, reinforcing that the prevailing trend remains downward.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Options positioning is extremely call-skewed (open interest put/call 0.04; volume put/call 0.03), which reflects strong bullish/speculative sentiment. Call open interest (3,418,367) dwarfs put open interest (149,106). Activity is elevated versus normal (today’s volume vs 30-day avg ~37.36), suggesting heightened event/speculation interest. Volatility is very high (historical vol ~212.5%; 30d IV ~157.6%), though IV percentile/rank are relatively low (IV pct ~24.8; IV rank ~16.7), meaning implied volatility is not at peak levels versus its own history. Net: sentiment is aggressively bullish via calls, but this looks more like speculative positioning than a steady long-term signal—especially given the bearish chart.

Technical Summary

Sell

Buy

Positive Catalysts

1) Financing/capital-structure actions could improve runway: proceeds aimed at debt repayment and investments (preferred stock issuance and planned follow-on).
2) Wall Street support exists: Maxim initiated coverage with a Buy and a $1.50 target, highlighting scale, cleaner balance sheet approach, and expected BTC-asset scaling as capital markets activity expands the balance sheet.
3) Options market shows strong call demand, which can support short-term squeezes/bounces if price starts reclaiming key levels (pivot 0.945 then ~1.10).

Neutral/Negative Catalysts

1) Downtrend remains intact (bearish MA stack + worsening MACD), so rallies are more likely to be sold until trend flips.
2) Capital raise overhang: the $150M preferred follow-on plan can pressure the equity as the market digests funding needs and terms.
3) Extremely high volatility (HV > 200%) makes this unsuitable for most beginner long-term allocations, especially for an investor who doesn’t want to wait for optimal timing.
4) Near-term statistical/pattern outlook provided is negative (higher probability of declines over the next week).

Financial Performance

Latest quarter provided: 2025/Q3. Revenue rose to $1.543M (+660.39% YoY), which is strong growth but from a small base. Profitability is a major issue: net income was -$206.653M (loss expanded materially; the YoY percentage shown is extreme due to base effects), and EPS fell to -$0.24 (down 41.46% YoY). Gross margin listed at 100% suggests either a business model/accounting mix that doesn’t translate to bottom-line profitability yet. Overall: top-line growth is not currently converting into sustainable earnings, which weakens the long-term investment case at this time.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: only one notable update provided—on 2025-12-10, Maxim initiated coverage at Buy with a $1.50 price target (no other upgrades/downgrades or target revisions shown). Wall Street pros view (from the initiation): differentiated positioning in a digital-asset treasury strategy, expected rapid scaling of BTC assets, and financing via common/perpetual preferred viewed as a plus. Cons view (implied by current situation): high uncertainty and execution risk around scaling, heavy losses, and ongoing capital raising that can cap upside and increase risk for long-term investors.

1 Analyst Rating

Wall Street analysts forecast ASST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASST is 1.5 USD with a low forecast of 1.5 USD and a high forecast of 1.5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.801

Low

1.5

Averages

1.5

High

1.5

Current: 0.801

Low

1.5

Averages

1.5

High

1.5

Maxim

Buy

initiated

$1.50

AI Analysis

2025-12-10

Reason

Maxim

Price Target

$1.50

AI Analysis

2025-12-10

initiated

Buy

Reason

Maxim initiated coverage of Strive with a Buy rating and $1.50 price target. The company stands out in the digital-asset treasury space with scale, a clean balance sheet, a focus on common and perpetual preferred equity for financing, and deep macro experience, the analyst tells investors in a research note. Maxim adds that it expects rapid scaling of BTC assets as capital markets activity expands the balance sheet.

Benchmark

Buy

downgrade

$101 -> $86

2025-09-23

Reason

Benchmark

Price Target

$101 -> $86

2025-09-23

downgrade

Buy

Reason

Benchmark lowered the firm's price target on Semler Scientific (SMLR) to $86 from $101 and keeps a Buy rating on the shares after Semler agreed to be acquired by Strive (ASST) in an all-stock deal. While the market is sorting out the longer-term implications of the transaction, it appears to the firm that Semler shares \"represent an opportunity right now\" and that this deal seems to have \"rung the opening bell for consolidation in the corporate bitcoin treasury space,\" the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ASST

Unlock Now

ASST Should I Buy

ASST Should I Buy

Should You Buy Strive Inc (ASST) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch